Isabel Tecu is a panelist on “Common Ownership and Passive Investments: The Next Frontier for Section 7?.”
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
